๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT GLYCOSYLATED INTERLEUKIN 6 IN PATIENTS WITH CANCER: PHARMACOKINETICS, PHARMACODYNAMICS AND IMMUNOMODULATORY EFFECTS

โœ Scribed by Rosamonde E Banks; Mary A Forbes; Poulam M Patel; Mark Storr; Susan Hallam; Deborah Clarke; Daniela Novick; Eileen Ingham; Christopher Bowmer; Jennifer Southgate; Ludwik K Trejdosiewicz; John Illingworth; Timothy J Perren; Peter J Selby


Book ID
115596391
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
170 KB
Volume
12
Category
Article
ISSN
1043-4666

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Subcutaneous recombinant gamma interfero
โœ John A. Thompson; W. Welby Cox; Catherine G. Lindgren; Carolyn Collins; Kathryn ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› Springer-Verlag ๐ŸŒ English โš– 750 KB

Recombinant gamma interferon (ry-IFN) was administered s. c. daily to 26 patients with advanced cancer. Patients were assigned to one of six doses: 0.5, 1, 2, 4, 6, or 8 million units (MU)/m 2 per d. The major toxicities were an influenza-like syndrome and fever, seen in all patients. Dose limiting